182 related articles for article (PubMed ID: 3927970)
1. Cumulative antiplatelet effect of low-dose enteric coated aspirin.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Deykin D
Br J Haematol; 1985 Aug; 60(4):635-42. PubMed ID: 3927970
[TBL] [Abstract][Full Text] [Related]
2. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
[TBL] [Abstract][Full Text] [Related]
3. Single-dose effect of enteric-coated aspirin on platelet function and thromboxane generation in middle-aged men.
Mohri H; Ohkubo T
Ann Pharmacother; 1993 Apr; 27(4):405-10. PubMed ID: 8477113
[TBL] [Abstract][Full Text] [Related]
4. Effects of enteric-coated, low-dose aspirin on parameters of platelet function.
Van Hecken A; Juliano ML; Depré M; De Lepeleire I; Arnout J; Dynder A; Wildonger L; Petty KJ; Gottesdiener K; De Hoon JN
Aliment Pharmacol Ther; 2002 Sep; 16(9):1683-8. PubMed ID: 12197849
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
Preston FE; Greaves M; Jackson CA; Stoddard CJ
Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic actions of aspirin in the horse.
Cambridge H; Lees P; Hooke RE; Russell CS
Equine Vet J; 1991 Mar; 23(2):123-7. PubMed ID: 1904347
[TBL] [Abstract][Full Text] [Related]
7. Enteric-coated aspirin, platelet cyclooxygenase activity and function.
Rao GH; Radh E; Johnson GJ; White JG
Prostaglandins Leukot Med; 1984 Mar; 13(3):341-7. PubMed ID: 6425869
[TBL] [Abstract][Full Text] [Related]
8. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
Cox D; Maree AO; Dooley M; Conroy R; Byrne MF; Fitzgerald DJ
Stroke; 2006 Aug; 37(8):2153-8. PubMed ID: 16794200
[TBL] [Abstract][Full Text] [Related]
9. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
Bode-Böger SM; Böger RH; Schubert M; Frölich JC
Eur J Clin Pharmacol; 1998; 54(9-10):707-14. PubMed ID: 9923572
[TBL] [Abstract][Full Text] [Related]
10. Effect of alternate-day regular and enteric-coated aspirin on platelet aggregation, bleeding time, and thromboxane A2 levels in bleeding-time blood.
Stampfer MJ; Jakubowski JA; Deykin D; Schafer AI; Willett WC; Hennekens CH
Am J Med; 1986 Sep; 81(3):400-4. PubMed ID: 3529953
[TBL] [Abstract][Full Text] [Related]
11. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
May JA; Heptinstall S; Cole AT; Hawkey CJ
Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
[TBL] [Abstract][Full Text] [Related]
12. Dose- and time-dependent antiplatelet effects of aspirin.
Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
[TBL] [Abstract][Full Text] [Related]
13. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
14. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency.
Fuse I; Ootsuka T; Hattori A; Mito M; Shibata A
Int J Hematol; 1996 Jun; 63(4):317-24. PubMed ID: 8762815
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis.
Brown N; May JA; Wilcox RG; Allan LM; Wilson AM; Kiff PS; Heptinstall S
Br J Clin Pharmacol; 1999 Jul; 48(1):57-62. PubMed ID: 10383561
[TBL] [Abstract][Full Text] [Related]
16. Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin.
Rao GH; Johnson GJ; Reddy RK; White JG
Prostaglandins; 1981 Nov; 22(5):761-72. PubMed ID: 6799989
[TBL] [Abstract][Full Text] [Related]
17. Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase.
Buchanan MR; Rischke JA; Hirsh J
Thromb Res; 1982 Mar; 25(5):363-73. PubMed ID: 7071811
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
Vial JH; McLeod LJ; Roberts MS; Seville PR
Aust N Z J Med; 1990 Oct; 20(5):652-6. PubMed ID: 2126726
[TBL] [Abstract][Full Text] [Related]
19. The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery.
Vanags D; Rodgers SE; Lloyd JV; Bochner F
Thromb Res; 1990 Sep; 59(6):995-1005. PubMed ID: 2264023
[TBL] [Abstract][Full Text] [Related]
20. The effect of acetylsalicylic acid in 3 different formulations on in vitro and in vivo platelet function tests. An experimental study on healthy male volunteers.
Kutti J; Safai-Kutti S; Sigvaldason A; Edgar B; Lundborg P
Scand J Haematol; 1984 Apr; 32(4):379-84. PubMed ID: 6719042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
